For this reason, temporary inpatient sliding scale insulin protocols have become common despite risks of hypoglycemia.26 Our finding that nearly half of intensifications were for new insulin, primarily short-acting insulins, may represent high-risk carryover of inpatient regimens to the outpatient setting. Here, INS is linked to Hypoglycemia.